Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to 8.12%.

  • Bioventus' EBIT Margin rose 54900.0% to 8.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.05%, marking a year-over-year increase of 119700.0%. This contributed to the annual value of 2.09% for FY2024, which is 138600.0% up from last year.
  • Bioventus' EBIT Margin amounted to 8.12% in Q3 2025, which was up 54900.0% from 12.44% recorded in Q2 2025.
  • In the past 5 years, Bioventus' EBIT Margin registered a high of 26.9% during Q2 2021, and its lowest value of 98.58% during Q4 2022.
  • For the 5-year period, Bioventus' EBIT Margin averaged around 8.72%, with its median value being 0.86% (2023).
  • Per our database at Business Quant, Bioventus' EBIT Margin crashed by -976200bps in 2022 and then surged by 1005800bps in 2023.
  • Over the past 5 years, Bioventus' EBIT Margin (Quarter) stood at 2.42% in 2021, then crashed by -414bps to 12.43% in 2022, then surged by 107bps to 0.86% in 2023, then surged by 726bps to 7.11% in 2024, then grew by 14bps to 8.12% in 2025.
  • Its EBIT Margin was 8.12% in Q3 2025, compared to 12.44% in Q2 2025 and 3.93% in Q1 2025.